New Anticancer Therapeutics Based on Luminescent Transition Metal Complexes


   School of Mathematical and Physical Sciences

   Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. While these chemotherapeutics have been hugely successful, many forms of cancer are intrinsically resistant to the chemotherapeutics and others can rapidly acquire resistance to these treatments. We have identified new ruthenium-based metal complexes that are promising leads for cancer treatment. Because they work in a very different way to platinum-based drugs they are active in resistant cancer cells such as cisplatin-resistant ovarian cancer. In this multidisciplinary project you will gain experience - and be trained in - organic and inorganic synthesis, and a range of cell biology skills, including various forms of state-of-the-art microscopy.

Chemistry (6)

How good is research at University of Sheffield in Chemistry?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Register your interest for this project



Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.